Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 21, 2010; 16(27): 3347-3357
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3347
Published online Jul 21, 2010. doi: 10.3748/wjg.v16.i27.3347
Type | Definition |
A | Acute and hyperacute liver failure |
B | Portosystemic bypass without intrinsic hepatocellular disease |
C | Cirrhosis and portal hypertension with portosystemic shunts |
Encephalopathy | Definition |
Acute | Acute liver dysfunction |
Recurrent or episodic | Episodes of mental alteration in a patient with cirrhosis, even in the absence of a known precipitating factor |
Persistent | Neurological deficit that persists despite the reversal of liver injury, such as following liver transplantation or the removal of a precipitating factor |
Minimal (previously known as subclinical) | No evidence of overt encephalopathy, but subtle cognitive deficits might be detected with a neuropsychological function test battery |
Precipitating factors | Ammonia load e.g. upper gastrointestinal bleed or portocaval shunt |
Inflammation/oxidative stress | |
Infection | |
Dehydration | |
Hyponatremia | |
Sedative drugs e.g. benzodiazepines |
- Citation: Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: Role of inflammation and oxidative stress. World J Gastroenterol 2010; 16(27): 3347-3357
- URL: https://www.wjgnet.com/1007-9327/full/v16/i27/3347.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i27.3347